794591-77-8 Usage
Uses
Used in Chemical Reactions and Synthesis Processes:
7-Bromo-3H-pyrido[3,4-d]pyridazin-4-one serves as a key intermediate in various chemical reactions and synthesis processes. Its unique structure allows it to be a versatile building block for the creation of more complex organic compounds.
Used in Medicinal Chemistry and Pharmaceutical Research:
In the field of medicinal chemistry, 7-Bromo-3H-pyrido[3,4-d]pyridazin-4-one is utilized as a starting material for the development of new pharmaceuticals. Its potential biological activities and unique structure make it a promising candidate for the design of novel therapeutic agents.
Used in Drug Discovery:
7-Bromo-3H-pyrido[3,4-d]pyridazin-4-one is employed in drug discovery efforts to identify and optimize compounds with potential therapeutic benefits. Its properties and reactivity contribute to the advancement of new drug candidates for various medical conditions.
Used in Organic Chemistry Research:
7-BroMo-3H-pyrido[3,4-d]pyridazin-4-one is also used in organic chemistry research to study the properties and reactions of heterocyclic compounds. Understanding its behavior can lead to insights that benefit the broader field of organic chemistry and the development of new synthetic methods.
Check Digit Verification of cas no
The CAS Registry Mumber 794591-77-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,9,4,5,9 and 1 respectively; the second part has 2 digits, 7 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 794591-77:
(8*7)+(7*9)+(6*4)+(5*5)+(4*9)+(3*1)+(2*7)+(1*7)=228
228 % 10 = 8
So 794591-77-8 is a valid CAS Registry Number.
794591-77-8Relevant academic research and scientific papers
SUBSTITUTED-1-PHTHALAZINAMINES AS VR-1 ANTAGONISTS
-
Page 21, (2010/02/09)
The present invention provides a compound of formula (I): in which Ar and R1 are phenyl or a heteroaromatic group, R2 is generally hydrogen, R3 is hydrogen or alkyl and X, Y and Z are generally CH or N as VR-1 antagonists; or a pharmaceutically acceptable salt thereof; pharmaceutical compositions comprising it; its use in therapy; use of it to manufacture medicaments to treat pain or inflammation; and methods of treating pain or inflammation.